Treatment of sympathetic overactivity in tetanus.
D000328:Adult; D000368:Aged; D000768:Anesthesia, General; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D002648:Child; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D004562:Electrocardiography; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006221:Halothane; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008297:Male; D009609:Nitrous Oxide; D011433:Propranolol / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D013610:Tachycardia / Q000188:drug therapy / Q000209:etiology; D013742:Tetanus / Q000150:complications* / Q000378:metabolism; D014241:Trichloroethylene
D006146:Guanidines; D014241:Trichloroethylene; D011433:Propranolol; D009609:Nitrous Oxide; D002746:Chlorpromazine; D006221:Halothane